Sabra Healthcare REIT (SBRA) Stock Price, News & Analysis

Company Overview

Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Key Stats

• Today's Range: $18.56 to $18.80
• 50-Day Range: $17.48 to $18.76
• 52-Week Range: $15.60 to $20.03
• Volume: 2.60 million shs
• Average Volume: 2.47 million shs
• Market Capitalization: $4.49 billion
• P/E Ratio: 24.63
• Dividend Yield: 6.41%
• Price Target: $20.00
• Consensus Rating: Moderate Buy

Sabra Healthcare REIT Stock Analysis - MarketRank™

Sabra Healthcare REIT scored higher than 32% of companies evaluated by MarketBeat, and ranked 779th out of 921 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Sabra Healthcare REIT has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Sabra Healthcare REIT has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 3.45%

Earnings Growth

Earnings for Sabra Healthcare REIT are expected to grow by 3.45% in the coming year, from $1.45 to $1.50 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Sabra Healthcare REIT is 24.63, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.85.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sabra Healthcare REIT is 24.63, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 19.31.

Price to Earnings Growth Ratio

Sabra Healthcare REIT has a PEG Ratio of 1.55. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Sabra Healthcare REIT has a P/B Ratio of 1.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.41% of the outstanding shares of Sabra Healthcare REIT have been sold short.

Short Interest Ratio / Days to Cover

Sabra Healthcare REIT has a short interest ratio ("days to cover") of 8.

Change versus previous month

Short interest in Sabra Healthcare REIT has recently increased by 1.56%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Sabra Healthcare REIT is a leading dividend payer. It pays a dividend yield of 6.41%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Sabra Healthcare REIT does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Sabra Healthcare REIT is 157.89%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on EPS estimates, Sabra Healthcare REIT will have a dividend payout ratio of 80.00% in the coming year. This indicates that Sabra Healthcare REIT may not be able to sustain their current dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

8.41% of the outstanding shares of Sabra Healthcare REIT have been sold short.

Short Interest Ratio / Days to Cover

Sabra Healthcare REIT has a short interest ratio ("days to cover") of 8.

Change versus previous month

Short interest in Sabra Healthcare REIT has recently increased by 1.56%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.07

News Sentiment

Sabra Healthcare REIT has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 21 news articles for Sabra Healthcare REIT this week, compared to 6 articles on an average week.

Search Interest

7 people have searched for SBRA on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Sabra Healthcare REIT to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Sabra Healthcare REIT insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $200,420.00 in company stock.

Percentage Held by Insiders

Only 1.10% of the stock of Sabra Healthcare REIT is held by insiders.

Percentage Held by Institutions

99.40% of the stock of Sabra Healthcare REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SBRA Stock Analysis - Frequently Asked Questions

How have SBRA shares performed this year?

Sabra Healthcare REIT's stock was trading at $17.32 on January 1st, 2025. Since then, SBRA shares have increased by 8.1% and is now trading at $18.72.

How were Sabra Healthcare REIT's earnings last quarter?

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) announced its quarterly earnings results on Monday, August, 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT's revenue for the quarter was up 7.4% on a year-over-year basis.
Read the conference call transcript.

Who are Sabra Healthcare REIT's major shareholders?

Top institutional investors of Sabra Healthcare REIT include Geode Capital Management LLC (2.76%), Bank of New York Mellon Corp (1.75%), Bank of Montreal Can (1.08%) and Advisors Capital Management LLC (0.94%). Insiders that own company stock include Michael Lourenco Costa, Michael J Foster and Catherine Cusack.
View institutional ownership trends.

How do I buy shares of Sabra Healthcare REIT?

Shares of SBRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Sabra Healthcare REIT own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sabra Healthcare REIT investors own include NVIDIA (NVDA), AT&T (T), Meta Platforms (META), Verizon Communications (VZ), Chevron (CVX), Tesla (TSLA) and Exxon Mobil (XOM).

Company Calendar

• Record date for 5/30 Dividend: 5/16/2025
• Ex-Dividend for 5/30 Dividend: 5/16/2025
• Dividend Payable: 5/30/2025
• Last Earnings: 8/04/2025
• Today: 8/10/2025
• Record date for 8/29 Dividend: 8/15/2025
• Ex-Dividend for 8/29 Dividend: 8/15/2025
• Dividend Payable: 8/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: REIT - EQTY TRUST - OTHER
• Sub-Industry: Specialized REITs
• Current Symbol: NASDAQ:SBRA
• CIK: 1492298
• Web: www.sabrahealth.com
• Phone: (888) 393-8248
• Fax: 949-679-8868
• Employees: 40
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Sabra Healthcare REIT: $20.00
• High Price Target: $22.00
• Low Price Target: $18.00
• Potential Upside/Downside: +6.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.71
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.76
• Trailing P/E Ratio: 24.63
• Forward P/E Ratio: 12.91
• P/E Growth: 1.55
• Net Income: $126.71 million
• Net Margins: 24.87%
• Pretax Margin: 24.85%
• Return on Equity: 6.69%
• Return on Assets: 3.44%

Debt

• Debt-to-Equity Ratio: 0.91
• Current Ratio: 4.80
• Quick Ratio: 4.22

Sales & Book Value

• Annual Sales: $733.04 million
• Price / Sales: 6.12
• Cash Flow: $1.25 per share
• Price / Cash Flow: 14.95
• Book Value: $11.31 per share
• Price / Book: 1.66

Miscellaneous

• Outstanding Shares: 239,792,000
• Free Float: 236,914,000
• Market Cap: $4.49 billion
• Optionable: Optionable
• Beta: 0.86